Muscular dystrophy, incurability, eugenics

Area of Science:

• Neurology
• Medical Ethics
• Public Health

Background:

• Muscular dystrophy is frequently portrayed in public discourse as a severe, incurable condition.
• This perception has fueled campaigns advocating for euthanasia laws, using muscular dystrophy as a model disease.
• The public image of muscular dystrophy often misrepresents the realities of patient life and treatment advancements.

Purpose of the Study:

• To challenge the public perception of muscular dystrophy as an incurable disease.
• To analyze the ethical implications of the incurability dogma in the context of muscular dystrophy.
• To present the patient perspective on end-of-life decisions and treatment.

Main Methods:

• Review of current medical literature on muscular dystrophy treatments and prognosis.
• Analysis of public opinion campaigns and media representation of the disease.
• Consultation with patients to understand their views on quality of life and treatment.

Main Results:

• Empirical treatments for muscular dystrophy have significantly extended patient lifespans, often doubling life expectancy.
• The majority of consulted patients do not favor euthanasia, even when facing severe symptoms.
• The belief in incurability can lead to adverse outcomes, including social injustice and eugenic practices.

Conclusions:

• The notion of muscular dystrophy as an incurable disease is inaccurate given current treatment efficacy.
• Promoting euthanasia based on the incurability dogma poses significant ethical risks, including social injustice and eugenics.
• Patient-centered care and accurate information are crucial to counter misinformation and support informed decision-making.